Pyxis Oncology, Inc. (PYXS) Free cash flow 2020–2025
Pyxis Oncology, Inc. (PYXS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$63.5MFY2025 · since FY2020: -$11.6M → -$63.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$63.5M | -9.7% |
| FY2024 | -$57.9M | +25.2% |
| FY2023 | -$77.4M | +19.1% |
| FY2022 | -$95.7M | -166.9% |
| FY2021 | -$35.9M | -210.1% |
| FY2020 | -$11.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice